Introduction Migraine is the second largest cause of years lived with disability and the 14th leading cause of disability-adjusted life years globally (Steiner et al., Reference Steiner, Stovner, Jensen, Uluduz and Katsarava2020).
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Manjit Matharu
Can an Intravenous Anti-CGRP Therapy Change Treatment Expectations in Migraine?
Should Patients Expect More From Their Migraine Therapy? Brendan Davies Davies began by highlighting the substantial burden that migraine imposes on patients, the workforce, and primary and secondary care. Data from the UK reveal that nearly one-third of migraine sufferers have moved from full-time to part-time work due to the condition, and a quarter have left their job entirely.
Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi‐country results from the CaMEO‐I study
AHS American Headache Society AMPP American Migraine Prevalence and Prevention AMS American Migraine Study ASC-12 Allodynia Symptom Checklist CaMEO Chronic Migraine Epidemiology and Outcomes CaMEO-I Chronic Migraine Epidemiology and Outcomes-International CGRP calcitonin gene–related peptide mAb monoclonal antibody MHD monthly headache day mICHD-3 modified International Classification of Headache Disorders, 3rd edition MIDAS Migraine Disability Assessment Scale MSSS Migraine Symptom Severity...
Facial pain in MS: When to think of trigeminal autonomic cephalalgia
Giuliani and colleagues report a patient with multiple sclerosis (MS) who developed short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT). The patient had a demyelinating lesion in the pons close to the trigeminal root entry zone and responded to treatment with lamotrigine.1 SUNCT is a rare headache syndrome classed as a trigeminal autonomic cephalalgia (TAC).
Trigeminal Neuralgia: A Practical Guide
Welcome to the new home for Guidelines Clinical guideline summaries and expert articles for UK healthcare professionals all in one place. | Disclosures | New 13 June 2023 Dr Georgio Lambru The Headache Service, Pain Management and Neuromodulation Centre, Guy's and St Thomas' Hospitals NHS Trust, London, UK Professor Joanna Zakrzewska Facial Pain Clinic, Eastman Dental Hospital, London, UK.
A case of recurrent flight-induced cerebrospinal fluid shunt overdrainage
Abstract Shunted patients often complain of headaches after flights. The effect of air travel on shunt systems is unknown. We describe the case of a patient with longstanding hydrocephalus, who suffered flight-induced clinical deterioration and shunt overdrainage in two independent occasions. The patient, clinically stable for 1.5 and 5 years before each episode, reported severe headaches starting during the descent stages of the air travel.
Trigeminal neuralgia: a practical guide
Trigeminal neuralgia: a practical guide Giorgio Lambru1, Joanna Zakrzewska2,3, http://orcid.org/0000-0002-4960-2294Manjit Matharu4,5 1 The Headache Service, Pain Management and Neuromodulation Centre, Guy's and St Thomas' Hospitals NHS Trust, London, UK 2 Facial Pain Clinic, Eastman Dental Hospital, London, UK 3 Pain Management Centre, University College London Hospitals NHS Foundation Trust, London, UK 4 Headache and Facial Pain Group, UCL Queen Square Institute of Neurology, London, UK 5...
Trigeminal neuralgia: a practical guide
Trigeminal neuralgia: a practical guide Giorgio Lambru1, Joanna Zakrzewska2,3, http://orcid.org/0000-0002-4960-2294Manjit Matharu4,5 1The Headache Service, Pain Management and Neuromodulation Centre, Guy's and St Thomas' Hospitals NHS Trust, London, UK 2Facial Pain Clinic, Eastman Dental Hospital, London, UK 3Pain Management Centre, University College London Hospitals NHS Foundation Trust, London, UK 4Headache and Facial Pain Group, UCL Queen Square Institute of Neurology, London, UK...
Miners' Nystagmus Following Visual Deprivation: A Case Report
Acknowledgment: The authors thank the patient and her partner for allowing them to publish her story; the neuro-ophthalmology department at the National Hospital for Neurology and Neurosurgery, London, for performing visual assessments; and Professor David Zee for providing invaluable historical data.
Non-invasive vagus nerve stimulation is beneficial in chronic paroxysmal hemicrania
Non-invasive vagus nerve stimulation is beneficial in chronic paroxysmal hemicrania Salwa Kamourieh1, Susie Lagrata1, Manjit Singh Matharu1,2 1 Headache Group, The National Hospital for Neurology and Neurosurgery, London, UK 2 UCL Institute of Neurology, London, UK Correspondence to Dr Manjit Singh Matharu, Headache Group, Institute of Neurology and The National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK; m.matharu{at}uclmail.net Statistics from Altmetric.com...
Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus; a multi-center retrospective case-control study
Apart from the recognised association between antiphospholipid antibodies and cerebrovascular disease [3], biomarkers previously thought to show great promise in the management of NPSLE, such as anti-ribosomal P antibodies [17] and anti N-methyl-D-aspartate receptor antibodies [18], have not come into widespread clinical use.
Neurostimulation in the treatment of primary headaches
Neurostimulation in the treatment of primary headaches Sarah Miller1, Alex J Sinclair2, Brendan Davies3, Manjit Matharu1 1Headache Group, Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UK 2Neurometabolism, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, The University of Birmingham, Birmingham, UK 3Department of Neurology, Royal Stoke University Hospital, Stoke-on-Trent, UK Correspondence to Dr Alex J Sinclair,...
Headache management: pharmacological approaches
Headache is one of the most common conditions presenting to the neurology clinic, yet a significant proportion of these patients are unsatisfied by their clinic experience. Headache can be extremely disabling; effective treatment is not only essential for patients but is rewarding for the physician.
Headache management: pharmacological approaches
Headache is one of the most common conditions presenting to the neurology clinic, yet a significant proportion of these patients are unsatisfied by their clinic experience. Headache can be extremely disabling; effective treatment is not only essential for patients but is rewarding for the physician.
Neurostimulation in the treatment of primary headaches
There is increasing interest in using neurostimulation to treat headache disorders. There are now several non-invasive and invasive stimulation devices available with some open-label series and small controlled trial studies that support their use. Non-invasive stimulation options include supraorbital stimulation (Cefaly), vagus nerve stimulation (gammaCore) and single-pulse transcranial magnetic stimulation (SpringTMS).
Neurostimulation in the treatment of primary headaches
There is increasing interest in using neurostimulation to treat headache disorders. There are now several non-invasive and invasive stimulation devices available with some open-label series and small controlled trial studies that support their use. Non-invasive stimulation options include supraorbital stimulation (Cefaly), vagus nerve stimulation (gammaCore) and single-pulse transcranial magnetic stimulation (SpringTMS).
Neurostimulation in the treatment of primary headaches
There is increasing interest in using neurostimulation to treat headache disorders. There are now several non-invasive and invasive stimulation devices available with some open-label series and small controlled trial studies that support their use. Non-invasive stimulation options include supraorbital stimulation (Cefaly), vagus nerve stimulation (gammaCore) and single-pulse transcranial magnetic stimulation (SpringTMS).
Exacerbation of SUNCT and SUNA syndromes during intravenous dihydroergotamine treatment: A case series
Background The management of short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) and with short-lasting unilateral neuralgiform headache attacks with autonomic symptoms (SUNA) remains challenging in view of the limited understanding of their pathophysiological mechanisms.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Manjit
Contact Manjit, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack